ArticleProceedings of the National Academy of Sciences of the United States of America2017

Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.

Meredith L Stone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.